Note to our followers: Due to a lack of sufficient funding, will cease daily publication of new content at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. If you wish to donate, your gift might help keep the site available to the public for a few more years, by defraying costs of web hosting and maintenance. All of our 6,000+ published articles contain lessons to help people improve their critical thinking about health care. Read more about our change in status. And here's how to make a donation.

Categories: industry/commercial news releases


Time to test all infants’ gut microbiomes — or is this a product in search of a condition?


Recap of lung cancer screening test relies on hyperbole, conjecture to market preliminary result


There’s no justification for claiming new blood test is ‘94% accurate’ compared to PSA test for prostate cancer

2 8/10/2018

Big Cherry claims about health benefits leave a sour taste in our mouths


Model suggests liquid biopsy improves prostate cancer outcomes, but that’s not the real world


Claims that torn meniscus can be regenerated based on single case study wither under scrutiny


Announcement oversells blood test for predicting treatment outcomes in prostate cancer


Here’s a prime example of how Big Pharma issues misleading news releases to journalists


Janssen’s claim that Xarelto benefits frail patients better than warfarin built on frail research


Recap promises ‘results’ of dry eye drug study but doesn’t deliver